September 11, 2007 — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated with concomitant use of ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Amid growing ...
The FDA has notified healthcare professionals of an update to a previous alert from September 2007 addressing the interaction of ceftriaxone with calcium-containing products. At the FDA’s request, ...
(WHNT) — The Alabama Department of Public Health issued a statement Wednesday about its current investigation into certain “adverse events” following an injection. In the news release, ADPH said it is ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
PHOENIX -- Administering ceftriaxone prophylactically in the intensive care unit (ICU) reduced the risk of ventilator-associated pneumonia (VAP) among patients with an acute brain injury, a randomized ...
Review the side-effects of Ceftriaxone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
July 6, 2007 (updated September 11, 2007) — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results